http://7thspace.com/headlines/416401/title_adjuvant_effect_of_docetaxel_on_the_immune_responses_to_influenza_a_h1n1_vaccine_in_mice.html
Posted by Rob LW
hVIVO is the new name of Retroscreen Virology! (from 15 April 2015). hVIVO is a rapidly growing UK life sciences company pioneering a technology platform which uses human challenge models of disease involving healthy volunteers to study new drugs and investigate disease in a safe, controlled, clinical environment. Our belief is that the best way to understand human disease is by studying it in humans, not laboratory models.
No comments:
Post a Comment